News & Updates
  • Home
  • About Us
  • Contact
  • Home 1
  • News & Updates

    Tomovircona, a Novel RNAi-Based Virucide by Silicon Gene Technologies (Shanghai) Co., Ltd., Receives ISO approval

    Patented New ISO Name Approved – December 2025: Triflupyroxazin, A New N-phenylimide Herbicide From Liaoning Cynda Chemical Co., Ltd.

    Patented New ISO Name Approved – December 2025: Amfenamacril, A New Aminocyanoacrylate Fungicide From Jiangsu Pesticide Research Institute Co., Ltd.

    Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19

    adminJanuary 15, 202201.5k views

    Synopsis : Novartis and Molecular Partners announced that Part A of the EMPATHY clinical trial(1) that compared single intravenous doses of ensovibep,…

    Read more

    Bayer and Mammoth Biosciences to collaborate on novel gene editing technology

    adminJanuary 15, 202201.9k views

    Synopsis : Bayer AG and Mammoth Biosciences, Inc., which is harnessing the diversity of nature to power the next-generation CRISPR products, today…

    Read more

    Amgen and Arrakis Therapeutics announce multi-target collaboration to identify novel RNA degrader small molecule therapeutics

    adminJanuary 14, 202201.8k views

    Synopsis : Amgen  and Arrakis Therapeutics today announced a research collaboration focused on the discovery and development of RNA degrader therapeutics against…

    Read more

    Glenmark gets US FDA nod for Nasal Spray to treat seasonal Allergic Rhinitis

    adminJanuary 14, 202201.6k views

     Synopsis : With this NDA approval, the company looks forward to bringing this new medicine to physicians and their patients for the…

    Read more

    Bharat Biotech seeks full marketing approval from DCGI for Covaxin

    adminJanuary 14, 202202.1k views

    Synopsis : Bharat Biotech has sought from the Drugs Controller General of India (DCGI) regular market approval for its COVID-19 vaccine Covaxin’,…

    Read more

    JPM 2022: Eli Lilly gears up for Alzheimer’s-diabetes juggling act as 2 key FDA decisions loom

    adminJanuary 14, 202202k views

    Summary : On the brink of two major approvals this year, Eli Lilly is laser-focused on diabetes and dementia. One market is…

    Read more

    AstraZeneca sells another half-million doses of its COVID-19 antibody combo to the US

    adminJanuary 14, 202201.8k views

    Summary : Order up. Shortly after topping off supplies of COVID-19 drugs from Pfizer and GlaxoSmithKline, the U.S. has asked for a…

    Read more

    European Commission approves Cystic Fibrosis Treatment for six to 11-year-olds

    adminJanuary 14, 202201.6k views

    Summary : There is currently no cure for cystic fibrosis (CF), a debilitating, progressive condition with over 10,830 people in the UK…

    Read more

    Oxford joins Consortium to advance Quantum Drug Discovery

    adminJanuary 14, 202201.9k views

    Summary : -The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order…

    Read more

    New study finds AstraZeneca booster generates higher antibodies against Omicron

    adminJanuary 14, 202201.5k views

    Summary : AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria. The results from…

    Read more

    Posts navigation

    1 … 63 … 105
    View Desktop Version

    Powered by PenciDesign

    Back To Top